Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’" is generating significant coverage in the Health category, with 10 articles from 10 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Standard-Examiner, Oncodaily, Medscape and OncLive. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 94d ago.
Quick answers
Why is "Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘G" trending?
Because 10 independent news sources published 10 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (10)
- Intermountain Hospitals in Ogden, Layton to be among first to administer new pancreatic cancer drug Standard-Examiner · 97d ago
- Arturo Loaiza-Bonilla: Daraxonrasib Brings New Hope to Pancreatic Cancer Patients Oncodaily · 97d ago
- Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib Medscape · 101d ago
- Cracking the KRAS Code: Daraxonrasib's Practice-Changing Data in Pancreatic Cancer and Beyond OncLive · 101d ago
- Stanford expands access to revolutionary pancreatic cancer drug Stanford Medicine · 101d ago
- New drug delivers promising survival gains in pancreatic cancer News-Medical · 101d ago
- FDA Accepts daraxonrasib Application for RAS-Mutant Pancreatic Cancer The Clinical Trial Vanguard · 101d ago
- Breakthrough Drug Brings Hope to Utah Grandfather with Pancreatic Cancer University of Utah Health · 101d ago
- Letter to the editor: Good news for patients NH Business Review · 101d ago
- Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ Chicago Tribune · 101d ago
Topics
Related trends
College basketball rankings: Michigan State vs. Tennessee, Duke vs. Illinois highlight huge Tuesday
College basketball rankings heat up with Michigan State vs. Tennessee and Duke vs. Illinois
Game Observations: 8 takeaways from the Patriots Week 10 loss to the Lions in Munich
The Detroit Lions routed the New England Patriots in Munich while rookie quarterback Drake Maye suffered an injury, prompting widespread scrutiny of New England's direction.
Nebraska Claims Big Ten Regular Season Title Outright With Sweep
Top-ranked Nebraska volleyball swept No. 25 Illinois to claim the outright 2026 Big Ten regular-season championship.
Preview & Picks: Illinois at No. 4 UCLA
Undefeated No. 4 UCLA hosts Illinois at the Rose Bowl on Friday night in a key Big Ten matchup.
Illinois ban on hemp-derived THC drinks paused for businesses part of federal lawsuit
Illinois has agreed to pause enforcement of its ban on hemp-derived THC drinks for about 250 businesses that sued the state, granting a temporary reprieve until at least Nov. 19.
What time, TV channel is Oregon vs. Ohio State? Game preview, prediction, betting line
Oregon rallied from a 14-0 deficit to beat No. 11 Ohio State 41-28, scoring 38 straight points in Columbus.